EP0695171A1 - Lyospheres contenant de la gonadotrophine - Google Patents

Lyospheres contenant de la gonadotrophine

Info

Publication number
EP0695171A1
EP0695171A1 EP94915121A EP94915121A EP0695171A1 EP 0695171 A1 EP0695171 A1 EP 0695171A1 EP 94915121 A EP94915121 A EP 94915121A EP 94915121 A EP94915121 A EP 94915121A EP 0695171 A1 EP0695171 A1 EP 0695171A1
Authority
EP
European Patent Office
Prior art keywords
lyospheres
gonadotropin
preparation
well
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP94915121A
Other languages
German (de)
English (en)
Other versions
EP0695171B1 (fr
Inventor
Arnold Titus Philip Skrabanja
Herman Vromans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Priority to EP94915121A priority Critical patent/EP0695171B1/fr
Publication of EP0695171A1 publication Critical patent/EP0695171A1/fr
Application granted granted Critical
Publication of EP0695171B1 publication Critical patent/EP0695171B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

L'invention concerne des lyosphères contenant de la gonadotrophine, leur préparation ainsi que des préparations pharmaceutiques les contenant.
EP94915121A 1993-04-28 1994-04-25 Lyospheres contenant de la gonadotrophine Expired - Lifetime EP0695171B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP94915121A EP0695171B1 (fr) 1993-04-28 1994-04-25 Lyospheres contenant de la gonadotrophine

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93201215 1993-04-28
EP93201215 1993-04-28
EP94915121A EP0695171B1 (fr) 1993-04-28 1994-04-25 Lyospheres contenant de la gonadotrophine
PCT/EP1994/001303 WO1994025005A1 (fr) 1993-04-28 1994-04-25 Lyospheres contenant de la gonadotrophine

Publications (2)

Publication Number Publication Date
EP0695171A1 true EP0695171A1 (fr) 1996-02-07
EP0695171B1 EP0695171B1 (fr) 1996-12-18

Family

ID=8213798

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94915121A Expired - Lifetime EP0695171B1 (fr) 1993-04-28 1994-04-25 Lyospheres contenant de la gonadotrophine

Country Status (16)

Country Link
US (1) US5656597A (fr)
EP (1) EP0695171B1 (fr)
JP (1) JPH08509483A (fr)
KR (1) KR100334856B1 (fr)
AT (1) ATE146360T1 (fr)
AU (1) AU679986B2 (fr)
CA (1) CA2150251C (fr)
DE (1) DE69401204T2 (fr)
DK (1) DK0695171T3 (fr)
ES (1) ES2098140T3 (fr)
FI (1) FI112324B (fr)
GR (1) GR3022510T3 (fr)
HK (1) HK1002017A1 (fr)
NO (1) NO311168B1 (fr)
NZ (1) NZ265956A (fr)
WO (1) WO1994025005A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120202A (en) * 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
GB2329124B (en) * 1997-09-12 2002-05-08 Hiran Asoka Malinga Ratwatte Method of forming dose units of active agents
DK1165050T3 (da) 1999-04-05 2006-05-01 Mannkind Corp Fremgangsmåde til dannelse af fint pulver
EP1658840A1 (fr) * 1999-04-05 2006-05-24 Mannkind Corporation Procédé de formation d'une poudre fine
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
EP1894591B1 (fr) 2002-03-20 2013-06-26 MannKind Corporation Cartouche pour un appareil d'inhalation
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US20060222694A1 (en) * 2003-06-27 2006-10-05 Oh Choon K Stabilized topotecan liposomal composition and methods
DK1786784T3 (da) 2004-08-20 2011-02-14 Mannkind Corp Katalyse af diketopiperazinsyntese
CN104436170B (zh) 2004-08-23 2018-02-23 曼金德公司 用于药物输送的二酮哌嗪盐
HUE028623T2 (en) 2005-09-14 2016-12-28 Mannkind Corp Active substance formulation method based on increasing the affinity of the active ingredient for binding to the surface of crystalline microparticles
IN2015DN00888A (fr) 2006-02-22 2015-07-10 Mannkind Corp
TWI436789B (zh) 2008-01-21 2014-05-11 Intervet Int Bv 含有藥學化合物的顆粒之冷凍乾燥方法及含有此顆粒的藥學包
MX2010008799A (es) 2008-03-05 2010-09-07 Sanofi Pasteur Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2570400T3 (es) 2008-06-13 2016-05-18 Mannkind Corp Un inhalador de polvo seco y un sistema para el suministro de fármacos
JP5479465B2 (ja) 2008-06-20 2014-04-23 マンカインド コーポレイション 吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2405963B1 (fr) 2009-03-11 2013-11-06 MannKind Corporation Appareil, système et procédé de mesure de résistance d'un inhalateur
KR101875969B1 (ko) 2009-06-12 2018-07-06 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
MX359281B (es) 2010-06-21 2018-09-21 Mannkind Corp Sistema y metodos para suministrar un farmaco en polvo seco.
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
WO2012174472A1 (fr) 2011-06-17 2012-12-20 Mannkind Corporation Microparticules de dicétopipérazine de capacité élevée
CN103945859A (zh) 2011-10-24 2014-07-23 曼金德公司 用于治疗疼痛的方法和组合物
WO2014012069A2 (fr) 2012-07-12 2014-01-16 Mannkind Corporation Systèmes et procédés de libération de médicament en poudre sèche
EP2911690A1 (fr) 2012-10-26 2015-09-02 MannKind Corporation Compositions et procédés de vaccin antigrippal inhalable
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3362052A4 (fr) * 2015-10-16 2019-06-19 Merck Sharp & Dohme Corp. Procédés pour préparer des préparations pour thérapies ciblant le tractus gastro-intestinal

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
DE3264450D1 (en) * 1981-12-11 1985-08-01 Wyeth John & Brother Ltd Process and apparatus for freezing a liquid medium
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
DE69005800T2 (de) * 1989-05-01 1994-05-19 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9425005A1 *

Also Published As

Publication number Publication date
KR950703934A (ko) 1995-11-17
FI112324B (fi) 2003-11-28
FI953442A0 (fi) 1995-07-14
NO954320L (no) 1995-10-27
NZ265956A (en) 1996-09-25
NO954320D0 (no) 1995-10-27
CA2150251A1 (fr) 1994-11-10
HK1002017A1 (en) 1998-07-24
GR3022510T3 (en) 1997-05-31
ES2098140T3 (es) 1997-04-16
AU679986B2 (en) 1997-07-17
DE69401204D1 (de) 1997-01-30
EP0695171B1 (fr) 1996-12-18
JPH08509483A (ja) 1996-10-08
DK0695171T3 (da) 1997-06-02
ATE146360T1 (de) 1997-01-15
CA2150251C (fr) 2005-02-22
NO311168B1 (no) 2001-10-22
AU6648894A (en) 1994-11-21
KR100334856B1 (ko) 2002-11-07
US5656597A (en) 1997-08-12
WO1994025005A1 (fr) 1994-11-10
FI953442A (fi) 1995-07-14
DE69401204T2 (de) 1997-06-05

Similar Documents

Publication Publication Date Title
EP0695171A1 (fr) Lyospheres contenant de la gonadotrophine
CA2275392A1 (fr) Nouvelles preparations medicamenteuses aqueuses pour la production d'aerosols depourvus de gaz propulseur
CA2109259A1 (fr) Precurseurs de medicaments, leur preparation et leur utilisation en pharmaceutique
ZA965294B (en) Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
GR3031711T3 (en) Cephalosporins and homologues, preparations and pharmaceutical compositions.
IL111533A0 (en) Quinoxalinedione derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
AU2974189A (en) Pharmaceutical compositions containing lactams, new substituted lactams and processes for the preparation thereof
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU8315287A (en) New alkanesulfonanilide and alkylaminosulfonanilide derivatives, processes for their preparation and pharmaceutical compositions comprising the same
ZA93821B (en) New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them.
AU2837089A (en) New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
AU7230194A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
AU8146994A (en) Novel taxicine derivatives, their preparation and pharmaceutical compositions containing them
AU7705196A (en) Pesticide compounds, compositions and process for the preparation thereof
EP0630963A3 (fr) Micro-émulsion acide.
CA2169696A1 (fr) Derives de substitution de benzenesulfonylurees et de thiourees; methodes de preparation et utilisation de preparations pharmaceutiques a base de ces composes; medicaments qui en renferment
AU7996194A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing them
AU4504893A (en) Novel 10-diacetyl baccatine iii derivatives, preparation thereof and pharmaceutical compositions containing them
AU6263190A (en) Extracellular exopolymer, process for its preparation and pharmaceutical compositions containing the said exopolymer
AU4318397A (en) Novel 2,4-dioxopyrrolidine and 2,4-dioxotetrahydrofuran derivatives and medicines containing the same as the active ingredient
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA2299503A1 (fr) Composes inhibant l'effet de premier passage
EP0729950A4 (fr) Medicament anti-vih

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950516

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

17Q First examination report despatched

Effective date: 19960313

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

REF Corresponds to:

Ref document number: 146360

Country of ref document: AT

Date of ref document: 19970115

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ISLER & PEDRAZZINI AG

ET Fr: translation filed
REF Corresponds to:

Ref document number: 69401204

Country of ref document: DE

Date of ref document: 19970130

ITF It: translation for a ep patent filed
REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: 71147

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2098140

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: GR

Ref legal event code: FG4A

Free format text: 3022510

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

NLS Nl: assignments of ep-patents

Owner name: N.V. ORGANON

Effective date: 20061027

REG Reference to a national code

Ref country code: PT

Ref legal event code: PC4A

Owner name: N.V. ORGANON, NL

Effective date: 20061124

REG Reference to a national code

Ref country code: CH

Ref legal event code: PUE

Owner name: N.V. ORGANON

Free format text: AKZO NOBEL N.V.#VELPERWEG 76#6824 BM ARNHEM (NL) -TRANSFER TO- N.V. ORGANON#KLOOSTERSTRAAT 6#5349 AB OSS (NL)

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

NLT1 Nl: modifications of names registered in virtue of documents presented to the patent office pursuant to art. 16 a, paragraph 1

Owner name: N.V. ORGANON

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: ISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH)

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20110426

Year of fee payment: 18

Ref country code: SE

Payment date: 20110425

Year of fee payment: 18

Ref country code: GR

Payment date: 20110429

Year of fee payment: 18

Ref country code: IE

Payment date: 20110426

Year of fee payment: 18

Ref country code: PT

Payment date: 20110408

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20110429

Year of fee payment: 18

Ref country code: AT

Payment date: 20110401

Year of fee payment: 18

Ref country code: BE

Payment date: 20110426

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20110423

Year of fee payment: 18

REG Reference to a national code

Ref country code: NL

Ref legal event code: SD

Effective date: 20120116

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFUS

Owner name: MSD OSS B.V., NL

Free format text: FORMER OWNER: N.V. ORGANON, NL

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

Owner name: MSD OSS B.V., NL

Effective date: 20120207

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20120308 AND 20120314

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69401204

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69401204

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

Effective date: 20120619

Ref country code: DE

Ref legal event code: R081

Ref document number: 69401204

Country of ref document: DE

Owner name: MERCK SHARP & DOHME B.V., NL

Free format text: FORMER OWNER: N.V. ORGANON, 5349 OSS, NL

Effective date: 20120619

Ref country code: DE

Ref legal event code: R081

Ref document number: 69401204

Country of ref document: DE

Owner name: MERCK, SHARP & DOHME B.V., NL

Free format text: FORMER OWNER: N.V. ORGANON, 5349 OSS, NL

Effective date: 20120619

BERE Be: lapsed

Owner name: *ORGANON N.V.

Effective date: 20120430

REG Reference to a national code

Ref country code: PT

Ref legal event code: MM4A

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20121025

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

REG Reference to a national code

Ref country code: SE

Ref legal event code: EUG

REG Reference to a national code

Ref country code: AT

Ref legal event code: MM01

Ref document number: 146360

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120425

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: GR

Ref legal event code: ML

Ref document number: 970400207

Country of ref document: GR

Effective date: 20121102

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120425

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120430

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121025

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120426

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121102

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120425

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20130326

Year of fee payment: 20

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFUS

Owner name: MERCK SHARP AND DOHME B.V., NL

Free format text: FORMER OWNER: ORGANON BIO SCIENCES NEDERLAND B.V., NL

Ref country code: CH

Ref legal event code: PFUS

Owner name: ORGANON BIO SCIENCES NEDERLAND B.V., NL

Free format text: FORMER OWNER: MSD OSS B.V., NL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69401204

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20130715

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120426

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20130430

Year of fee payment: 20

Ref country code: CH

Payment date: 20130426

Year of fee payment: 20

REG Reference to a national code

Ref country code: NL

Ref legal event code: SD

Effective date: 20130814

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

Owner name: MERCK SHARP & DOHME B.V., NL

Effective date: 20130724

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 69401204

Country of ref document: DE

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE

Effective date: 20130705

Ref country code: DE

Ref legal event code: R081

Ref document number: 69401204

Country of ref document: DE

Owner name: MERCK SHARP & DOHME B.V., NL

Free format text: FORMER OWNER: MSD OSS B.V., 5349 OSS, NL

Effective date: 20130705

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20130417

Year of fee payment: 20

Ref country code: NL

Payment date: 20130409

Year of fee payment: 20

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20131003 AND 20131009

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20120430

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69401204

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69401204

Country of ref document: DE

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: NL

Ref legal event code: V4

Effective date: 20140425

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20140424

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20140424

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20140426